[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Merus N.V. Common Shares (MRUS) Genmab to acquire Merus for $X billion, sending shares soaring. Positive clinical trial data and the acquisition have driven the stock to a 1-year high. ### About Merus N.V. Common Shares Merus N.V. Common Shares (MRUS) is a biopharmaceutical company developing cancer therapeutics. Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the [Stocks](/list/stocks) and category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights [#](/topic/$mrus/insights) - Merus N.V. Common Shares (MRUS) social dominance hit XXXX which is XXX% higher than it's daily average. - Merus N.V. Common Shares (MRUS) social dominance is up XXXXXXXX% from the previous month. - Merus N.V. Common Shares (MRUS) galaxy scoreβ’ is up XXXXXX% from the previous month. - Merus N.V. Common Shares (MRUS) sentiment is up XXX% from the previous week. - Merus N.V. Common Shares (MRUS) posts created is up XXXXXX% from the previous month. ### Price: $XXXXX [#](/topic/$mrus/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/close.tsv) The XXXXX% price surge in MRUS is driven by positive clinical trial results, analyst upgrades, and high social media engagement, with the stock price currently at $84.80, hitting a 1-year high, and the positive news indicates a likely continuation of the upward trend. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | XXXX% | XXXX% | XXXXX% | **1-Year High**: $XX on 2025-10-15 **1-Year Low**: $XXXXX on 2025-04-08 ### AltRank: XXX [#](/topic/$mrus/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/alt_rank.tsv) Merus N.V. Common Shares (MRUS) is currently AltRank #478 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXX +239 **1 Month**: XXX -XXXXX **6 Months**: XXX -XXXXX **1 Year**: XXX +103 **1-Year High**: XXXXX on 2025-08-12 **1-Year Low**: XX on 2025-05-25 ### Galaxy Score: XX [#](/topic/$mrus/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1 Week**: XX +42 **1 Month**: XX +61 **6 Months**: XX +24 **1 Year**: XX +49 **1-Year High**: XX on 2025-07-10 **1-Year Low**: XX on 2025-09-19 ### Engagements: XXXXXX [#](/topic/$mrus/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/interactions.tsv) **Current Value**: XXXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXXXX +339% **6 Months**: XXXXXXXXX +221% **1 Year**: XXXXXXXXX -XX% **1-Year High**: XXXXXXX on 2025-09-29 **1-Year Low**: XXX on 2025-10-20 | Social Network | X | YouTube | Reddit | | -------------- | - | ------- | ------ | | Engagements | XXXXXX | X | X | ### Mentions: XX [#](/topic/$mrus/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XXX **1 Month**: XXX +105% **6 Months**: XXXXX +332% **1 Year**: XXXXX +545% **1-Year High**: XXXXX on 2025-07-10 **1-Year Low**: X on 2025-10-20 | Social Network | X | YouTube | Reddit | | -------------- | - | ------- | ------ | | Mentions | XXX | X | X | ### Creators: XX [#](/topic/$mrus/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XXX +217% **6 Months**: XXXXX +738% **1 Year**: XXXXX +737% **1-Year High**: XXX on 2025-09-30 **1-Year Low**: X on 2025-10-20 The most influential creators that mention Merus N.V. Common Shares in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | XXX | | [@SamFazeli8](/creator/twitter/SamFazeli8) | X | XXXXX | X | XXX | | [@MichelleF_Davis](/creator/twitter/MichelleF_Davis) | X | XXXXX | X | XXX | | [@PersimmonTI](/creator/twitter/PersimmonTI) | X | XXXXXX | X | XX | | [@jfais20](/creator/twitter/jfais20) | X | XXXXXX | X | XX | | [@Fredbenz0](/creator/twitter/Fredbenz0) | X | XXXXX | X | XX | | [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | X | XXX | X | XX | | [@SteveDJacobs](/creator/twitter/SteveDJacobs) | X | XXXXX | X | XX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XX | | [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | XX | XXX | X | XX | [View More](/list/creators/$mrus/100) ### Sentiment: XX% [#](/topic/$mrus/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% +50% **1 Month**: XXX% +25% **6 Months**: XXX% no change **1 Year**: XXX% +25% **1-Year High**: XXX% on 2025-01-26 **1-Year Low**: X% on 2024-11-17 **Most Supportive Themes** - **Positive Clinical Trial Data:** (60%) Positive clinical trial results of Merus's drug, petosemtamab, particularly its high response and survival rates in head and neck cancer patients. - **Analyst Price Target Increases:** (20%) Several social media posts highlight analysts raising price targets for MRUS based on the promising clinical trial data. - **Acquisition by Genmab:** (15%) Genmab is acquiring Merus for $XX per share in cash, a deal valued at $X billion. **Most Critical Themes** - **Trial Data Comparison Concerns:** (1%) Some users are expressing concerns over comparing trial results with different patient populations and treatment contexts. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXX | XX% | XX | X% | | YouTube | X | X% | X | X% | X | X% | | Reddit | X | X% | X | X% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XX | X% | ### Social Dominance: XXXXXXX% [#](/topic/$mrus/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/social_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXXX% +0.0022% **1 Month**: XXXX% +0.047% **6 Months**: XXXX% +0.043% **1 Year**: XXXX% +0.045% **1-Year High**: XXXX% on 2025-05-25 **1-Year Low**: XXXXXX% on 2025-09-22 ### Market Dominance: XXXXXXX% [#](/topic/$mrus/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/market_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-31 **1-Year Low**: XXXXXXX% on 2025-02-14 ### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mrus/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXX +$0.68% **1 Month**: $XXXXXXXXXXXXX +$39% **6 Months**: $XXXXXXXXXXXXX +$141% **1 Year**: $XXXXXXXXXXXXX +$100% **1-Year High**: $XXXXXXXXXXXXX on 2025-10-15 **1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08 **Top assets mentioned** In the posts about Merus N.V. Common Shares in the last XX hours [Bitcoin Incognito (XBI)](/topic/$xbi) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Akropolis (AKRO)](/topic/$akro) [Landwolf (WOLF)](/topic/$wolf) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [AstraZeneca PLC (AZN)](/topic/$azn) [Pfizer, Inc. (PFE)](/topic/$pfe) [Merck & Co., Inc. (MRK)](/topic/$mrk) **Top topics mentioned** In the posts about Merus N.V. Common Shares in the last XX hours [$gmab](/topic/$gmab), [$gmabco](/topic/$gmabco), [acquisition](/topic/acquisition), [stocks technology](/topic/stocks-technology), [$8b](/topic/$8b), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [$xbi](/topic/$xbi), [$psnl](/topic/$psnl), [stocks financial services](/topic/stocks-financial-services), [$mtsr](/topic/$mtsr), [$akro](/topic/$akro), [$etnb](/topic/$etnb), [investment](/topic/investment), [breakthrough](/topic/breakthrough), [$wolf](/topic/$wolf), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [johnson johnson](/topic/johnson-johnson), [$rna](/topic/$rna), [$argx](/topic/$argx), [$asnd](/topic/$asnd), [stocks real estate](/topic/stocks-real-estate), [$azn](/topic/$azn), [$pfe](/topic/$pfe), [$mrk](/topic/$mrk), [stocks communication services](/topic/stocks-communication-services), [investments](/topic/investments), [$abvx](/topic/$abvx), [$mstr](/topic/$mstr), [$crdo](/topic/$crdo), [$pltr](/topic/$pltr), [summary](/topic/summary), [ticker](/topic/ticker), [combo](/topic/combo), [exit](/topic/exit), [dawn protocol](/topic/dawn-protocol), [coins defi](/topic/coins-defi), [$cart](/topic/$cart), [$tlry](/topic/$tlry), [$jnj](/topic/$jnj), [$etor](/topic/$etor), [$fro](/topic/$fro), [$tmc](/topic/$tmc), [$arct](/topic/$arct), [$ewtx](/topic/$ewtx), [$mdgl](/topic/$mdgl), [$idya](/topic/$idya), [$apge](/topic/$apge), [$bntx](/topic/$bntx), [$sobi](/topic/$sobi), [$as](/topic/$as), [$asml](/topic/$asml), [stocks banks](/topic/stocks-banks), [$frmi](/topic/$frmi), [$lgo](/topic/$lgo), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [advanced micro devices](/topic/advanced-micro-devices), [electronic arts inc](/topic/electronic-arts-inc), [$pcvx](/topic/$pcvx), [$ptct](/topic/$ptct), [costa rican colon](/topic/costa-rican-colon), [$mltx](/topic/$mltx), [$adct](/topic/$adct), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$8bn](/topic/$8bn), [$55bn](/topic/$55bn), [debt](/topic/debt), [$97shr](/topic/$97shr), [bloomberg](/topic/bloomberg), [upside](/topic/upside), [$dwtx](/topic/$dwtx), [corporate finance](/topic/corporate-finance), [$80b](/topic/$80b), [all the](/topic/all-the), [bank of](/topic/bank-of), [$idyas](/topic/$idyas), [$1325sh](/topic/$1325sh), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [novo](/topic/novo), [$novcde](/topic/$novcde), [$52b](/topic/$52b), [$54share](/topic/$54share), [$ymab](/topic/$ymab), [$sndx](/topic/$sndx), [$adv](/topic/$adv), [has been](/topic/has-been), [$zec](/topic/$zec), [gilead sciences](/topic/gilead-sciences), [$roiv](/topic/$roiv), [atai life](/topic/atai-life), [jacob](/topic/jacob), [$caba](/topic/$caba), [$vrna](/topic/$vrna), [$vyne](/topic/$vyne), [$insm](/topic/$insm), [aa](/topic/aa), [overnight](/topic/overnight), [scoop](/topic/scoop), [$mens](/topic/$mens), [$ford](/topic/$ford) ### Top Social Posts [#](/topic/$mrus/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$JNJ $MRUS $GMAB $MRK ESMO 2025: J&J brings a new Rybrevant use into the fold - After promising early data in head and neck J&J plans a new phase X Origami-5 -" [X Link](https://x.com/MarcJacksonLA/status/1979938716895662258) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-19T15:52Z 7583 followers, XXX engagements "$JNJ amivantamab an impressive XX% cORR in R/M. HNSCC. Slightly improved from the abstract. Starting a 1st line XXX patient P3 without CPS restrictions $GMAB $MRUS" [X Link](https://x.com/bio_clouseau/status/1979938503598186543) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-19T15:51Z 20K followers, 8582 engagements "$MRUS showing consolidation π with multiple UltraBuy signals π Are we gearing up for a breakout π #UltraAlgo #Trading" [Reddit Link](https://redd.it/1ntln3w) [@Short_Algo](/creator/reddit/Short_Algo) 2025-10-19T07:56Z X followers, X engagements "π US Exchanges 52-Week New Highs: $ATAI Atai Life Sciences N V $REKR Rekor Systems $CCO Clear Channel Outdoor $GILD Gilead Sciences $DGXX Digi Power X $ROIV Roivant Sciences $ASX Ase Industrial Holding $CVS CVS $MNST Monster Beverage $EL Estee Laudermpanies $MNMD Mind Medicine Mindmed $MRUS Merus N V CS $BG Bunge $XERS Xeris Pharmaceuticals $FIGS Figs #stockinfocus" [X Link](https://x.com/aipatternlab/status/1979571124909294014) [@aipatternlab](/creator/x/aipatternlab) 2025-10-18T15:31Z 4271 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Genmab to acquire Merus for $X billion, sending shares soaring. Positive clinical trial data and the acquisition have driven the stock to a 1-year high.
Merus N.V. Common Shares (MRUS) is a biopharmaceutical company developing cancer therapeutics.
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The XXXXX% price surge in MRUS is driven by positive clinical trial results, analyst upgrades, and high social media engagement, with the stock price currently at $84.80, hitting a 1-year high, and the positive news indicates a likely continuation of the upward trend.
24-Hour | 7-Day | 30-Day |
---|---|---|
XXXX% | XXXX% | XXXXX% |
1-Year High: $XX on 2025-10-15
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Merus N.V. Common Shares (MRUS) is currently AltRank #478 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +239
1 Month: XXX -XXXXX
6 Months: XXX -XXXXX
1 Year: XXX +103
1-Year High: XXXXX on 2025-08-12
1-Year Low: XX on 2025-05-25
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX +42
1 Month: XX +61
6 Months: XX +24
1 Year: XX +49
1-Year High: XX on 2025-07-10
1-Year Low: XX on 2025-09-19
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXXXX +339%
6 Months: XXXXXXXXX +221%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2025-10-20
Social Network | X | YouTube | |
---|---|---|---|
Engagements | XXXXXX | X | X |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX +105%
6 Months: XXXXX +332%
1 Year: XXXXX +545%
1-Year High: XXXXX on 2025-07-10
1-Year Low: X on 2025-10-20
Social Network | X | YouTube | |
---|---|---|---|
Mentions | XXX | X | X |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XXX +217%
6 Months: XXXXX +738%
1 Year: XXXXX +737%
1-Year High: XXX on 2025-09-30
1-Year Low: X on 2025-10-20
The most influential creators that mention Merus N.V. Common Shares in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@MarcJacksonLA | X | XXXXX | X | XXX |
@SamFazeli8 | X | XXXXX | X | XXX |
@MichelleF_Davis | X | XXXXX | X | XXX |
@PersimmonTI | X | XXXXXX | X | XX |
@jfais20 | X | XXXXXX | X | XX |
@Fredbenz0 | X | XXXXX | X | XX |
@EgidiusLambrech | X | XXX | X | XX |
@SteveDJacobs | X | XXXXX | X | XX |
@Biobeats99 | X | XXX | X | XX |
@TheOptionsBull2 | XX | XXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XXX% +25%
6 Months: XXX% no change
1 Year: XXX% +25%
1-Year High: XXX% on 2025-01-26
1-Year Low: X% on 2024-11-17
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXX | XX% | XX | X% |
YouTube | X | X% | X | X% | X | X% |
X | X% | X | X% | X | X% | |
Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% +0.0022%
1 Month: XXXX% +0.047%
6 Months: XXXX% +0.043%
1 Year: XXXX% +0.045%
1-Year High: XXXX% on 2025-05-25
1-Year Low: XXXXXX% on 2025-09-22
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.68%
1 Month: $XXXXXXXXXXXXX +$39%
6 Months: $XXXXXXXXXXXXX +$141%
1 Year: $XXXXXXXXXXXXX +$100%
1-Year High: $XXXXXXXXXXXXX on 2025-10-15
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Merus N.V. Common Shares in the last XX hours
Bitcoin Incognito (XBI) Metsera, Inc. Common Stock (MTSR) Akropolis (AKRO) Landwolf (WOLF) Johnson & Johnson (JNJ) Avidity Biosciences, Inc. Common Stock (RNA) AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK)
Top topics mentioned In the posts about Merus N.V. Common Shares in the last XX hours
$gmab, $gmabco, acquisition, stocks technology, $8b, stocks healthcare, stocks, $xbi, $psnl, stocks financial services, $mtsr, $akro, $etnb, investment, breakthrough, $wolf, stocks bitcoin treasuries, johnson johnson, $rna, $argx, $asnd, stocks real estate, $azn, $pfe, $mrk, stocks communication services, investments, $abvx, $mstr, $crdo, $pltr, summary, ticker, combo, exit, dawn protocol, coins defi, $cart, $tlry, $jnj, $etor, $fro, $tmc, $arct, $ewtx, $mdgl, $idya, $apge, $bntx, $sobi, $as, $asml, stocks banks, $frmi, $lgo, stocks consumer cyclical, advanced micro devices, electronic arts inc, $pcvx, $ptct, costa rican colon, $mltx, $adct, sarepta therapeutics inc, $8bn, $55bn, debt, $97shr, bloomberg, upside, $dwtx, corporate finance, $80b, all the, bank of, $idyas, $1325sh, akro akero therapeutics inc, novo, $novcde, $52b, $54share, $ymab, $sndx, $adv, has been, $zec, gilead sciences, $roiv, atai life, jacob, $caba, $vrna, $vyne, $insm, aa, overnight, scoop, $mens, $ford
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$JNJ $MRUS $GMAB $MRK ESMO 2025: J&J brings a new Rybrevant use into the fold - After promising early data in head and neck J&J plans a new phase X Origami-5 -"
X Link @MarcJacksonLA 2025-10-19T15:52Z 7583 followers, XXX engagements
"$JNJ amivantamab an impressive XX% cORR in R/M. HNSCC. Slightly improved from the abstract. Starting a 1st line XXX patient P3 without CPS restrictions $GMAB $MRUS"
X Link @bio_clouseau 2025-10-19T15:51Z 20K followers, 8582 engagements
"$MRUS showing consolidation π with multiple UltraBuy signals π Are we gearing up for a breakout π #UltraAlgo #Trading"
Reddit Link @Short_Algo 2025-10-19T07:56Z X followers, X engagements
"π US Exchanges 52-Week New Highs: $ATAI Atai Life Sciences N V $REKR Rekor Systems $CCO Clear Channel Outdoor $GILD Gilead Sciences $DGXX Digi Power X $ROIV Roivant Sciences $ASX Ase Industrial Holding $CVS CVS $MNST Monster Beverage $EL Estee Laudermpanies $MNMD Mind Medicine Mindmed $MRUS Merus N V CS $BG Bunge $XERS Xeris Pharmaceuticals $FIGS Figs #stockinfocus"
X Link @aipatternlab 2025-10-18T15:31Z 4271 followers, XXX engagements
/topic/$mrus